DK1578727T3 - Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer - Google Patents

Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer

Info

Publication number
DK1578727T3
DK1578727T3 DK03808299T DK03808299T DK1578727T3 DK 1578727 T3 DK1578727 T3 DK 1578727T3 DK 03808299 T DK03808299 T DK 03808299T DK 03808299 T DK03808299 T DK 03808299T DK 1578727 T3 DK1578727 T3 DK 1578727T3
Authority
DK
Denmark
Prior art keywords
receptor modulators
fsh receptor
tetrahydroquinoline derivatives
tetrahydroquinoline
derivatives
Prior art date
Application number
DK03808299T
Other languages
Danish (da)
English (en)
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1578727T3 publication Critical patent/DK1578727T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
DK03808299T 2002-12-20 2003-12-16 Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer DK1578727T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43547902P 2002-12-20 2002-12-20
EP02102865 2002-12-20
PCT/EP2003/051024 WO2004056779A2 (en) 2002-12-20 2003-12-16 Tetrahydroquinoline derivatives and their use as fsh receptor modulators

Publications (1)

Publication Number Publication Date
DK1578727T3 true DK1578727T3 (da) 2008-08-04

Family

ID=38799446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03808299T DK1578727T3 (da) 2002-12-20 2003-12-16 Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer

Country Status (23)

Country Link
US (1) US7674909B2 (es)
EP (1) EP1578727B1 (es)
JP (1) JP4545000B2 (es)
AR (1) AR042629A1 (es)
AT (1) ATE392416T1 (es)
AU (1) AU2003303221B2 (es)
BR (1) BR0317514A (es)
CA (1) CA2508923C (es)
CL (1) CL43546B (es)
DE (1) DE60320457T2 (es)
DK (1) DK1578727T3 (es)
ES (1) ES2304544T3 (es)
MX (1) MXPA05006772A (es)
NZ (1) NZ540577A (es)
PE (1) PE20040799A1 (es)
PL (1) PL376997A1 (es)
PT (1) PT1578727E (es)
RS (1) RS51196B (es)
RU (1) RU2328487C2 (es)
SI (1) SI1578727T1 (es)
TW (1) TWI322012B (es)
UA (1) UA80303C2 (es)
WO (1) WO2004056779A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2260458T3 (es) * 2001-07-02 2006-11-01 Akzo Nobel N.V. Derivados de tetrahidroquinolina.
TWI306855B (en) * 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
DE10260739B3 (de) 2002-12-23 2004-09-16 Outokumpu Oy Verfahren und Anlage zur Herstellung von Metalloxid aus Metallverbindungen
US7691848B2 (en) 2005-03-02 2010-04-06 Wyeth Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists
UA92008C2 (en) 2005-05-04 2010-09-27 Н.В. Органон 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
UA92007C2 (ru) * 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности
UA92009C2 (ru) 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия
DK1879866T3 (da) 2005-05-04 2011-06-06 Organon Nv Dihydropyridinderivater
US7687623B2 (en) 2005-05-12 2010-03-30 Wyeth Llc Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists
BRPI0609717A2 (pt) * 2005-05-12 2011-10-18 Wyeth Corp composto, e, métodos de preparação e fabricação do mesmo
CA2609714A1 (en) 2005-06-09 2006-12-21 Wyeth Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
TW200918058A (en) * 2007-08-31 2009-05-01 Organon Nv TSH receptor antagonizing tetrahydroquinoline compounds
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
WO2015074064A2 (en) * 2013-11-18 2015-05-21 Bair Kenneth W Tetrahydroquinoline compositions as bet bromodomain inhibitors
EP3071205B1 (en) 2013-11-18 2020-02-05 Forma Therapeutics, Inc. Benzopiperazine compositions as bet bromodomain inhibitors
MA50250A (fr) 2017-09-15 2020-07-22 Forma Therapeutics Inc Compositions de tétrahydroimidazo quinoléine utilisées en tant qu'inhibiteurs de cbp/p300
BR112020026783A2 (pt) 2018-06-29 2021-03-30 Forma Therapeutics, Inc. Inibição da proteína de ligação creb (cbp)
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2686182A (en) * 1950-12-07 1954-08-10 Basf Ag O-hydroxy-dihydro-quinoline carboxylic acids
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
NZ300739A (en) * 1994-12-22 2000-05-26 Ligand Pharm Inc Steroid receptor modulator compounds
JP4511042B2 (ja) * 1998-08-07 2010-07-28 メルク セローノ ソシエテ アノニム 不妊症の治療のためのfsh模倣物
US6200963B1 (en) * 1999-03-31 2001-03-13 American Home Products Corporation Aryl sulfonic acids as FSH antagonists
ES2260458T3 (es) * 2001-07-02 2006-11-01 Akzo Nobel N.V. Derivados de tetrahidroquinolina.
TWI306855B (en) * 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives

Also Published As

Publication number Publication date
RS51196B (sr) 2010-12-31
ES2304544T3 (es) 2008-10-16
MXPA05006772A (es) 2005-09-08
DE60320457D1 (de) 2008-05-29
JP2006512346A (ja) 2006-04-13
WO2004056779A2 (en) 2004-07-08
TWI322012B (en) 2010-03-21
CA2508923C (en) 2011-09-20
US20060167047A1 (en) 2006-07-27
EP1578727A2 (en) 2005-09-28
US7674909B2 (en) 2010-03-09
AR042629A1 (es) 2005-06-29
CA2508923A1 (en) 2004-07-08
SI1578727T1 (sl) 2008-08-31
BR0317514A (pt) 2005-11-16
PE20040799A1 (es) 2004-12-02
PT1578727E (pt) 2008-05-23
NZ540577A (en) 2006-12-22
WO2004056779A3 (en) 2004-08-12
DE60320457T2 (de) 2009-06-04
ATE392416T1 (de) 2008-05-15
CL43546B (es) 2005-04-08
TW200418471A (en) 2004-10-01
AU2003303221B2 (en) 2009-09-17
RS20050458A (en) 2007-08-03
AU2003303221A1 (en) 2004-07-14
UA80303C2 (en) 2007-09-10
JP4545000B2 (ja) 2010-09-15
RU2328487C2 (ru) 2008-07-10
RU2005122924A (ru) 2006-01-27
EP1578727B1 (en) 2008-04-16
PL376997A1 (pl) 2006-01-23

Similar Documents

Publication Publication Date Title
NO20055135D0 (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20052995D0 (no) 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer.
DK1578727T3 (da) Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer
NO20051451D0 (no) Pyrimidinderivater og deres anvendelse som CB2 modulatorer
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
DK1558615T3 (da) Purin-forbindelser og deres anvendelse som cannabinoid receptor ligander
NO20032842D0 (no) Karbazolderivater og deres anvendelse som neuropeptid Y5 reseptor ligander
DK1240164T3 (da) Benzazolderivater og deres anvendelse som JNK-modulatorer
NO20041008L (no) Karbazolderivater og anvendelse derav som NPY5 reseptor antagonister
NO20031952L (no) 3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
NO20043536L (no) Fluorsubstituerte sykloalkanoindoler og deres anvendelse som prostaglandin D2-reseptorantagonister
NO20023283D0 (no) Flammestopper
DK1368349T3 (da) Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler
DK1385825T3 (da) Substituerede 2-pyridincyclohexan-1,4-diaminderivater
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
NO20053569L (no) Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister
NO20024749L (no) Indolin-2-on-derivater, deres fremstilling og anvendelse som ocytocinreseptor-ligander
NO20034324L (no) Bipiperidinylderivater og deres anvendelse som kjemokin reseptorinhibitor
NO20034364L (no) Sapogenin-derivater, deres syntese og anvendelse samt metoder basert pa deres anvendelse
DK1492789T3 (da) Tropanderivater som CCR5-modulatorer
DK1636228T3 (da) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
NO20043580D0 (no) Quinazolinonderivater og deres bruk som CB agonister
DK1828137T3 (da) 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1587788T3 (da) 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer